Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 29 studies | 39% ± 18% | |
| pericyte | 10 studies | 26% ± 7% | |
| smooth muscle cell | 10 studies | 35% ± 16% | |
| connective tissue cell | 6 studies | 26% ± 8% | |
| endothelial cell | 4 studies | 34% ± 13% | |
| adventitial cell | 4 studies | 60% ± 10% | |
| myofibroblast cell | 4 studies | 76% ± 13% | |
| Mueller cell | 3 studies | 35% ± 10% | |
| chondrocyte | 3 studies | 36% ± 10% | |
| muscle cell | 3 studies | 32% ± 17% | |
| melanocyte | 3 studies | 29% ± 9% |
Insufficient scRNA-seq data for expression of PRELP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 85% | 21833.58 | 209 / 245 | 98% | 76.89 | 494 / 502 |
| lung | 95% | 35680.52 | 548 / 578 | 82% | 39.47 | 943 / 1155 |
| ovary | 99% | 35032.21 | 178 / 180 | 77% | 39.84 | 333 / 430 |
| breast | 89% | 22519.48 | 410 / 459 | 80% | 37.43 | 895 / 1118 |
| thymus | 85% | 18219.42 | 557 / 653 | 50% | 12.65 | 305 / 605 |
| uterus | 98% | 37487.37 | 167 / 170 | 37% | 16.64 | 171 / 459 |
| esophagus | 83% | 27291.72 | 1204 / 1445 | 44% | 13.40 | 81 / 183 |
| bladder | 90% | 42056.33 | 19 / 21 | 36% | 11.67 | 179 / 504 |
| skin | 50% | 9164.62 | 910 / 1809 | 75% | 38.19 | 352 / 472 |
| intestine | 83% | 26696.30 | 801 / 966 | 34% | 14.88 | 179 / 527 |
| blood vessel | 100% | 141647.30 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 96% | 32855.47 | 1157 / 1204 | 0% | 0 | 0 / 0 |
| pancreas | 3% | 339.88 | 10 / 328 | 88% | 73.32 | 157 / 178 |
| brain | 1% | 115.31 | 31 / 2642 | 88% | 21.44 | 621 / 705 |
| stomach | 42% | 9212.26 | 149 / 359 | 47% | 23.13 | 134 / 286 |
| spleen | 79% | 11753.31 | 190 / 241 | 0% | 0 | 0 / 0 |
| heart | 76% | 26452.96 | 658 / 861 | 0% | 0 | 0 / 0 |
| kidney | 21% | 3626.25 | 19 / 89 | 47% | 18.77 | 421 / 901 |
| adrenal gland | 16% | 1790.05 | 40 / 258 | 50% | 14.31 | 114 / 230 |
| eye | 0% | 0 | 0 / 0 | 61% | 19.62 | 49 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 53% | 16.29 | 24 / 45 |
| liver | 3% | 371.39 | 7 / 226 | 36% | 10.74 | 146 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 31% | 3.70 | 9 / 29 |
| muscle | 28% | 4003.95 | 226 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001501 | Biological process | skeletal system development |
| GO_0090398 | Biological process | cellular senescence |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005796 | Cellular component | Golgi lumen |
| GO_0043202 | Cellular component | lysosomal lumen |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_1903561 | Cellular component | extracellular vesicle |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0005201 | Molecular function | extracellular matrix structural constituent |
| GO_0008201 | Molecular function | heparin binding |
| GO_0030021 | Molecular function | extracellular matrix structural constituent conferring compression resistance |
| Gene name | PRELP |
| Protein name | PRELP protein Prolargin (Proline-arginine-rich end leucine-rich repeat protein) |
| Synonyms | SLRR2A |
| Description | FUNCTION: May anchor basement membranes to the underlying connective tissue. . |
| Accessions | ENST00000343110.3 P51888 Q6FHG6 |
